Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative midazolam and intraoperative dexmedetomidine in breast cancer surgery
ChiCTR2400093827Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in breast cancer comparing Preoperative midazolam + intraoperative dexmedetomidine, Preoperative midazolam and Preoperative placebo (3 arms). Primary endpoint: Postoperative 24-hour quality of recovery. Started Apr 2024; status: recruiting.
02
Drugs
midazolamdexmedetomidine
03
Conditions
breast cancer
Beyond the preview
Go deeper on ChiCTR2400093827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093827.